BioVie Inc (BIVI)
0.4864
0.00 (0.00%)
USD |
NASDAQ |
May 06, 16:00
0.48
-0.01
(-1.32%)
After-Hours: 20:00
BioVie Research and Development Expense (Quarterly): 6.470M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 6.470M |
| September 30, 2023 | 8.876M |
| June 30, 2023 | 8.300M |
| March 31, 2023 | 11.20M |
| December 31, 2022 | 7.033M |
| September 30, 2022 | 6.770M |
| June 30, 2022 | 5.873M |
| March 31, 2022 | 3.577M |
| December 31, 2021 | 4.714M |
| September 30, 2021 | 3.095M |
| June 30, 2021 | 0.5251M |
| March 31, 2021 | 0.7896M |
| December 31, 2020 | 0.9381M |
| September 30, 2020 | 0.1009M |
| June 30, 2020 | 0.1475M |
| March 31, 2020 | 0.3532M |
| December 31, 2019 | 0.3465M |
| September 30, 2019 | 0.3415M |
| June 30, 2019 | 0.2757M |
| March 31, 2019 | 0.3318M |
| December 31, 2018 | 0.206M |
| September 30, 2018 | 0.1945M |
| Date | Value |
|---|---|
| June 30, 2018 | 0.0957M |
| March 31, 2018 | 0.0464M |
| December 31, 2017 | 0.1868M |
| September 30, 2017 | 0.0419M |
| June 30, 2017 | 0.0905M |
| March 31, 2017 | 0.12M |
| December 31, 2016 | 0.1286M |
| September 30, 2016 | 0.1273M |
| June 30, 2016 | 0.0379M |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.0008M |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.0034M |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.0194M |
| December 31, 2013 | 0.0192M |
| September 30, 2013 | 0.0114M |
| June 30, 2013 | 0.00 |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.1009M
Minimum
Sep 2020
11.20M
Maximum
Mar 2023
3.670M
Average
3.095M
Median
Sep 2021
Research and Development Expense (Quarterly) Benchmarks
| Adial Pharmaceuticals Inc | 0.2644M |
| Precision BioSciences Inc | 13.39M |
| Cardiff Oncology Inc | 8.008M |
| Jaguar Health Inc | 3.463M |
| First Wave BioPharma Inc | 1.307M |